BioDesk is a division launched by Clinical Network Services (CNS) in 2011 to provide intelligent global product development and regulatory affairs consulting to biopharmaceutical and device companies.
BioDesk’s expert consultants offer CMC/manufacturing, toxicology, clinical/medical and regulatory affairs strategic advice for readying products to enter clinical trials or for marketing approval. BioDesk works closely with clients to design and implement manufacturing and non-clinical plans, mindful of commercial timelines and budgets.
BioDesk helps guide products efficiently through critical post-discovery development and into the clinic or ultimately for regulatory approval in key markets. The integrated nature of operations at CNS encourages a global development/ regulatory approach to ensure value is strategically added at every stage of the product development life cycle.
BioDesk provides an increasing international service to our clients with team members located in UK, USA and Australia.
For information about our team, click here.